Stock listing

TSXV:ASG Aurora Spine Corp. Stock

Home listing (TSXV) of Aurora Spine Corp.

Follow Aurora Spine Corp. into a list and get an email when it puts out news.

Share price · TSXV:ASG

$0.08 CAD 0.00 (0.0%)

Close on Nov 19, 2026

Past year -71.4% · daily closes, Nov 19, 2025 – Nov 19, 2026, adjusted for splits
Day range
$0.08 – $0.08 CADNov 19, 2026
Market cap
$6.25M CADAt the close on Nov 19, 2026 · price × 78.09M shares outstanding
52-week range
$0.07 – $0.315 CADLowest and highest trades, Nov 20, 2025 – Nov 19, 2026
Traded on an average day
$2,349 CADMedian day 2,111 shares · 23 days with no trades · last 3 months, Aug 19, 2026 – Nov 19, 2026
Aurora Spine Corp. logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
TSXV:ASG · Home$0.08 CAD0.00 (0.0%)—$0.08$0.08$0.08$0.08Close on Nov 19, 2026
OTC:ASAPF$0.052 USD-0.008 (-13.8%)25,000$0.052$0.052$0.052$0.060Close on Nov 20, 2026

Daily closes

Last 3 months, Aug 19, 2026 – Nov 19, 2026 · TSXV:ASG · CAD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$0.080.000.0%$0.08$0.08$0.080
$0.08-0.015-15.8%$0.085$0.085$0.0747,026
$0.0950.000.0%$0.095$0.095$0.0950
$0.0950.000.0%$0.095$0.095$0.0950
$0.095-0.005-5.0%$0.095$0.095$0.0951,000
$0.100.000.0%$0.10$0.10$0.100
$0.10+0.01+11.1%$0.10$0.10$0.101,504
$0.09-0.01-10.0%$0.10$0.10$0.0919,717
$0.100.000.0%$0.105$0.105$0.101,000
$0.100.000.0%$0.095$0.105$0.09520,000
$0.100.000.0%$0.10$0.10$0.100
$0.10-0.015-13.0%$0.10$0.10$0.102,222
$0.115+0.015+15.0%$0.115$0.115$0.11521,000
$0.10-0.015-13.0%$0.115$0.115$0.10164,021
$0.115-0.005-4.2%$0.125$0.125$0.11512,000
$0.120.000.0%$0.12$0.12$0.120
$0.120.000.0%$0.12$0.12$0.120
$0.12-0.01-7.7%$0.12$0.12$0.12131,515
$0.13+0.005+4.0%$0.13$0.13$0.13500
$0.125-0.005-3.8%$0.125$0.125$0.12540,000
$0.13+0.01+8.3%$0.125$0.13$0.1251,000
$0.120.000.0%$0.12$0.12$0.120
$0.120.000.0%$0.12$0.12$0.120
$0.120.000.0%$0.12$0.12$0.126,500
$0.120.000.0%$0.12$0.12$0.120
$0.12-0.02-14.3%$0.13$0.13$0.1253,000
$0.140.000.0%$0.14$0.14$0.14500
$0.140.000.0%$0.14$0.14$0.147,800
$0.14+0.01+7.7%$0.13$0.14$0.1372,000
$0.130.000.0%$0.13$0.13$0.130
$0.13-0.005-3.7%$0.13$0.13$0.1313,000
$0.135-0.005-3.6%$0.135$0.135$0.1352,000
$0.140.000.0%$0.14$0.14$0.140
$0.140.000.0%$0.14$0.14$0.140
$0.14+0.01+7.7%$0.15$0.15$0.145,000
$0.13-0.02-13.3%$0.135$0.135$0.133,000
$0.15+0.015+11.1%$0.15$0.15$0.151,500
$0.1350.000.0%$0.135$0.135$0.1350
$0.1350.000.0%$0.135$0.135$0.1350
$0.135+0.005+3.8%$0.135$0.135$0.13551,000
$0.13-0.02-13.3%$0.13$0.13$0.133,000
$0.150.000.0%$0.15$0.15$0.150
$0.150.000.0%$0.15$0.15$0.150
$0.150.000.0%$0.15$0.15$0.150
$0.15+0.005+3.4%$0.15$0.15$0.151,000
$0.1450.000.0%$0.145$0.145$0.1450
$0.145-0.005-3.3%$0.125$0.145$0.1252,500
$0.150.000.0%$0.15$0.15$0.1521,000
$0.15-0.005-3.2%$0.155$0.155$0.1529,600
$0.155-0.005-3.1%$0.165$0.165$0.1556,500
$0.160.000.0%$0.18$0.18$0.1618,500
$0.16-0.02-11.1%$0.19$0.20$0.1681,500
$0.180.000.0%$0.18$0.18$0.1815,500
$0.180.000.0%$0.18$0.18$0.180
$0.18-0.02-10.0%$0.195$0.20$0.1830,000
$0.20+0.01+5.3%$0.19$0.20$0.1927,000
$0.19+0.005+2.7%$0.18$0.19$0.1833,000
$0.185-0.02-9.8%$0.19$0.19$0.15581,000
$0.205+0.015+7.9%$0.205$0.205$0.2055,100
$0.190.000.0%$0.19$0.19$0.190
$0.19-0.025-11.6%$0.215$0.215$0.1947,700
$0.215-0.005-2.3%$0.215$0.215$0.2159,500
$0.220.000.0%$0.22$0.22$0.220
$0.220.000.0%$0.22$0.22$0.220
Ticker
TSXV:ASG
Asset type
Stock
Sector
Health care
Industry
Medical devices & supplies
Exchange
TSXV
Currency
CAD

What changed lately

Latest news

All Aurora Spine Corp. news

Aurora Spine Corp. on 6ix

Sector
Health care
Industry
Medical devices & supplies
News releases
14 in the last 12 months · 44 in all · newest Oct 22, 2026 · oldest 2013
Calls
18 calls with a replay · 18 with a transcript · latest May 28, 2026
Decks
4 decks · latest May 2026

Where Aurora Spine Corp. is listed

ListingExchangeCountryCurrency
TSXV:ASG · Home listing · This pageTSXVCanadaCAD
OTC:ASAPFOTCUnited StatesUSD
Cboe Canada:ASGCboe CanadaCanadaCAD

Cash and shares

May 2026 deck · Aurora Spine — Lytham Partners Spring 2026 Investor Conference

Shares outstanding
78.1 million

The slide these figures come from

Valuation

EV/sales 0.4× against a median of 0.2×: 5th lowest of 8 Medical devices & supplies companies shown. Statements: 4 quarters to Jun 30, 2026 · price Nov 19, 2026

Enterprise value
$9.91M CAD
P/E
Loss
EV/sales
0.4×
EV/EBITDA
45.6×
Price/book
1.5×
Gross margin
61.6%
Operating margin
−5.1%
Net margin
−7.0%
Debt to equity
1.0×
Beta vs S&P/TSX Composite
-0.13

Medical devices & supplies: the 10 companies nearest in size, of 448 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
Aurora Spine Corp. · TSXV:ASGUS$4.36MUS$6.91Mn/a0.4×45.6×1.5×−7.0%1.0×-0.13
MEKICS Co., Ltd. · KRX:058110US$5.23MUS$2.04M6.6×0.2×1.3×0.2×7.7%0.1×n/a
PT Hetzer Medical Indonesia Tbk · IDX:MEDSUS$5.16MUS$5.45Mn/an/an/a1.8×n/a0.1×n/a
Regentis Biomaterials Ltd. · AMEX:RGNTUS$5.05M−US$3.90Mn/an/an/a0.7×n/a0.0×2.00
SeaStar Medical Holding Corporation · NASDAQ:ICUUS$4.97MUS$981,429n/a0.5×n/a10.6×−678.2%0.0×1.44
WORK Medical Technology Group LTD · NASDAQ:WOKUS$4.84MUS$8.21Mn/a0.8×n/a0.2×−10.9%0.2×2.76
Kelyniam Global, Inc. · OTC:KLYGUS$4.56MUS$4.84Mn/a1.4×31.9×6.6×−6.0%0.6×1.15
Meihua International Medical Technologies Co., Ltd. · OTC:MHUAFUS$4.53M−US$1.63M0.7×−0.0×−0.2×0.0×11.0%0.1×0.62
IceCure Medical Ltd. · NASDAQ:ICCMUS$3.71M−US$3.80Mn/a−1.0×n/a0.4×−439.7%0.1×1.98
enVVeno Medical Corporation · NASDAQ:NVNOUS$3.65M−US$14.82Mn/an/an/a0.2×n/a0.0×1.12
Spineway SA · EURONEXT:ALSPWUS$3.63MUS$1.46Mn/a0.1×n/a0.1×−18.0%0.1×n/a
Median of the othersUS$4.70MUS$1.22M3.7×0.2×1.3×0.3×−10.9%0.1×1.44

Team and board

OfficerRole
Trent NorthcuttCEO
Chad ClouseChief Financial Officer
David MeyerCLO / Vice President
Katelyn SimsVice President of Commercialization & Key Accounts
Kenneth Scott CarnahanVice President of Education
Matt PaxtonExecutive Vice President of Sales
Ron EckelsGlobal Vice President of Spine
Laszlo GaramszegiCTO / Co-Founder
Matthew GoldstoneChief Commercial Officer

Events

Calls

CallWhenStatus
Aurora Spine (TSXV:ASG) Q1 2026 Earnings CallThu, May 28, 2026 · 10:00 AM ETReplay
Aurora Spine (TSXV:ASG) Q4 2025 Earnings CallThu, Apr 30, 2026 · 11:00 AM ETReplay
Aurora Spine (TSXV:ASG) Q3 2025 Earnings CallTue, Nov 18, 2025 · 11:00 AM ETReplay
Aurora Spine (TSXV:ASG) Q2 2025 Earnings CallTue, Sep 02, 2025 · 11:00 AM ETReplay
Aurora Spine (TSXV:ASG) Q1 2025 Earnings CallThu, May 22, 2025 · 11:00 AM ETReplay
Aurora Spine (TSXV:ASG) Q4 2024 Earnings CallTue, Apr 29, 2025 · 11:00 AM ETReplay
Aurora Spine (TSXV:ASG) Q3 2024 Earnings CallMon, Oct 28, 2024 · 11:00 AM ETReplay
Aurora Spine (TSXV:ASG) Q2 2024 Earnings CallFri, Aug 23, 2024 · 11:00 AM ETReplay
Aurora Spine (TSXV:ASG) Q1 2024 Earnings CallTue, May 14, 2024 · 11:00 AM ETReplay
Aurora Spine (TSXV:ASG) Q3 2023 Earnings CallWed, Nov 15, 2023 · 11:00 AM ETReplay
All 18 calls
CallWhenStatus
Aurora Spine (TSXV:ASG) Q2 2023 Earnings CallTue, Aug 29, 2023 · 12:00 PM ETReplay
Aurora Spine (TSXV:ASG) Q1 2023 Earnings CallWed, May 24, 2023 · 12:00 PM ETReplay
Aurora Spine (TSXV:ASG) Q4 2022 Earnings CallMon, May 01, 2023 · 12:00 PM ETReplay
Aurora Spine (TSXV:ASG) Q3 2022 Earnings CallMon, Nov 21, 2022 · 11:00 AM ETReplay
Aurora Spine (TSXV:ASG) Q2 2022 Earnings CallMon, Aug 29, 2022 · 11:00 AM ETReplay
Aurora Spine (TSXV:ASG) Q1 2022 Earnings CallTue, May 24, 2022 · 11:00 AM ETReplay
Aurora Spine (TSXV:ASG) Q4 2021 Earnings CallMon, May 02, 2022 · 1:10 PM ETReplay
Aurora Spine (TSXV:ASG) Q3 2021 Earnings CallTue, Nov 16, 2021 · 4:30 PM ETReplay

Results days

QuarterResultsShare move
Quarter to Sep 30, 2026Nov 19, 2026 · After close
Q1 2023May 24, 2023 · Before open−15.2%
Q3 2022Nov 21, 2022 · Before open0.0%
Q2 2022Aug 29, 2022 · Before open0.0%
Q1 2022May 23, 2022 · Before open−6.3%
Q3 2021Nov 16, 2021+1.4%
Quarter to Jun 30, 2021Aug 26, 2021+3.0%
Quarter to Mar 31, 2021May 27, 2021+7.5%

Open Events

Decks

DeckKindSlidesDate
Lytham Partners Spring 2026 Investor ConferenceConference17 slidesMay 2026
Investor Presentation (February 2026)Investor deck30 slidesFebruary 2026
Investor Presentation (2025)Investor deck29 slides2025
Investor Presentation (2025)Investor deck28 slides2025

Open Decks

Financials

Annual, in USD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue18.4M17.6M14.5M14.9M10.5M8.65M11.2M8.68M5.99M6.76M
Cost of revenue7.17M6.93M6.31M7.07M5.71M5.18M7.61M4.09M3.43M3.37M
Gross profit11.2M10.6M8.21M7.81M4.83M3.47M3.55M4.59M2.56M3.38M
Research and development624.3K731.3K1.11M1.16M941.3K286.2K207.5K36.3K21.1K40.4K
Selling, general and administrative9.64M9.34M6.82M6.08M4.99M3.65M3.89M3.64M3.70M4.11M
Operating income-330.0K-484.5K-1.50M-1.57M-2.71M-1.25M-1.25M-56.1K-2.33M-1.68M
Depreciation and amortization1.07M1.01M1.05M868.6K648.7K589.5K386.6K780.6K826.2K762.0K
EBITDA740.8K522.9K-446.2K-700.7K-2.06M-661.6K-866.8K724.4K-1.50M-917.2K
Interest expense168.3K175.1K185.2K163.6K159.1K90.8K174.0K147.6K144.7K60.9K
Income before tax-731.1K-1.00M-1.68M-1.50M-2.36M-232.1K-1.25M-68.2K-2.24M-1.68M
Income tax881.3K231.4K159.1K87.7K174.0K147.6K144.7K60.9K
Net income-731.1K-1.00M-1.68M-1.50M-2.36M-232.1K-1.25M-68.2K-2.24M-1.68M
Earnings per share, basic-0.01-0.01-0.02-0.02-0.04-0.00-0.03-0.00-0.06-0.05

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents896.7K825.6K766.8K423.4K3.17M1.71M444.7K856.5K12.7K192.8K
Receivables3.31M3.14M3.97M3.67M2.67M1.66M2.44M1.58M811.5K1.23M
Inventory3.24M3.61M3.56M3.05M1.89M1.60M1.53M2.56M2.46M3.00M
Current assets7.80M7.88M8.50M7.33M8.41M5.20M4.68M5.22M3.76M4.74M
Property, plant and equipment1.30M1.09M1.16M766.6K1.27M2.10M
Total assets10.4M11.1M12.0M10.1M10.6M7.16M6.67M6.84M5.29M7.04M
Accounts payable1.72M2.99M3.04M2.83M2.61M1.53M2.49M1.87M1.74M2.40M
Current liabilities3.35M3.27M3.27M3.03M2.63M1.56M2.52M1.87M1.74M2.40M
Long-term debt2.85M2.71M2.56M2.42M2.27M2.14M2.10M2.02M1.90M1.17M
Total debt3.65M2.97M2.38M2.34M2.41M2.02M
Total liabilities6.59M6.66M6.69M5.81M4.99M3.87M4.91M3.88M3.64M3.57M
Shareholders' equity3.81M4.40M5.30M4.32M5.57M3.28M1.77M2.96M1.65M3.47M
Shares outstanding78.1M77.6M70.7M66.8M58.7M54.6M46.5M42.2M35.2M32.2M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations917.4K1.06M-935.1K-1.56M-2.13M309.6K729435.8K-1.15M-1.70M
Capital spending-543.6K-637.9K-479.1K-873.2K-720.6K-554.6K-286.7K-292.7K-137.4K-91.4K
Free cash flow373.8K420.0K-1.41M-2.43M-2.85M-245.1K-286.0K143.1K-1.28M-1.79M
Cash from investing-720.6K-554.6K-283.9K-278.9K35.7K-91.4K
Cash from financing-302.7K-361.2K1.76M-318.2K4.31M1.51M-128.6K686.9K929.6K1.40M
Share buybacks350.2K394.2K
Change in cash71.1K58.8K343.4K-2.75M1.46M1.27M-411.8K843.8K-180.2K-386.8K

Open Financials

Cap table

Built by 6ix from Aurora Spine Corp.’s releases · as of Jun 30, 2026

Common shares
78,092,199
Fully diluted
80,112,199

Fully diluted

LineSharesAs of
Common shares78,092,199Jun 30, 2026
Options and RSUs2,020,000Jun 8, 2026

Warrants and options

Lot
Stock options · C$0.23 · expire about Jun 2031

Share count over time

CountShares
Jun 30, 202678,092,199

Open Cap table

Shareholders

InsiderTradeSharesPriceValueDate
Chad Clouse
Senior Officer of Issuer
Buy1,500CAD 0.24CAD 360May 6, 2026
Trent James Northcutt
10% Security Holder of Issuer
Buy500CAD 0.29CAD 148Feb 3, 2026
Trent James Northcutt
10% Security Holder of Issuer
Buy2,500CAD 0.31CAD 775Jan 27, 2026
Trent James Northcutt
10% Security Holder of Issuer
Buy2,250CAD 0.27CAD 596Jan 12, 2026
Trent James Northcutt
10% Security Holder of Issuer
Buy1,250CAD 0.29CAD 363Jan 5, 2026
Trent James Northcutt
10% Security Holder of Issuer
Buy4,000CAD 0.26CAD 1,040Dec 22, 2025
Trent James Northcutt
10% Security Holder of Issuer
Buy2,500CAD 0.27CAD 663Dec 4, 2025

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Chad ClouseChief Financial Officer · Since at least Oct 22, 2026
David MeyerCLO / Vice President · Since at least Nov 4, 2026
Katelyn SimsVice President of Commercialization & Key Accounts · Since at least Nov 4, 2026
Kenneth Scott CarnahanVice President of Education · Since at least Nov 4, 2026
Laszlo GaramszegiCTO / Co-Founder · Since at least Oct 22, 2026
Matthew GoldstoneChief Commercial Officer · Since at least Jun 10, 2025
Matt PaxtonExecutive Vice President of Sales · Since at least Nov 4, 2026
Ron EckelsGlobal Vice President of Spine · Since at least Sep 18, 2025
Trent J. NorthcuttCEO · Since at least Oct 22, 2026

Open People

Log in to ask 6ix AI your own questions about Aurora Spine Corp.